Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $11.26.
TDOC has been the topic of a number of recent analyst reports. Bank of America upped their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group lowered their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th.
Check Out Our Latest Stock Report on TDOC
Institutional Inflows and Outflows
Teladoc Health Stock Up 2.8 %
Shares of TDOC stock opened at $8.86 on Tuesday. The stock’s fifty day moving average price is $10.54 and its 200 day moving average price is $9.73. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $15.68. The company has a market cap of $1.54 billion, a price-to-earnings ratio of -1.54 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. On average, research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
- Five stocks we like better than Teladoc Health
- Why is the Ex-Dividend Date Significant to Investors?
- Can TikTok Stock Picks Really Make You Rich?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- The “Quality” Rotation: Back to Basics Investing
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.